Companies where 3+ insiders were net buyers in the selected period.
Last updated: May 16, 2026, 11:08 AM UTC
| Ticker | Company | Net Buyers | Net Amount | Net Shares | Details |
|---|---|---|---|---|---|
| KLRA | Kailera Therapeutics, Inc. | 5 | $326.8M | 20,421,876 | View Details |
| PSUS | Pershing Square USA, Ltd. | 8 | $311.4M | 6,309,171 | View Details |
| ALKT | ALKAMI TECHNOLOGY, INC. | 4 | $254.7M | 14,780,616 | View Details |
| MDLN | Medline Inc. | 3 | $225.3M | 7,547,371 | View Details |
| SGP | SpyGlass Pharma, Inc. | 15 | $221.5M | 13,842,500 | View Details |
| NAVN | Navan, Inc. | 5 | $173.9M | 11,288,964 | View Details |
| AKTS | Aktis Oncology, Inc. | 6 | $114.3M | 6,350,646 | View Details |
| NFRX | 2023 ETF Series Trust | 4 | $90.1M | 3,429,694 | View Details |
| ODTX | Odyssey Therapeutics, Inc. | 7 | $75.3M | 4,181,997 | View Details |
| MANE | Veradermics, Inc | 5 | $53.1M | 2,785,614 | View Details |